Supplements and repurposed drugs
-
Aspirin reduced DFS events 39% in PIK3CA exon 9/20 tumours
A meta-analysis of three randomised trials found fewer disease-free survival events with adjuvant aspirin in colorectal tumours carrying PIK3CA exon 9 or 20 mutations. The ASCOLT trial’s own…